Monsters in the Attic

November 28, 2012 – Falling prices for generics have restrained overall U.S. spending on medicine, but there are monsters lurking in the attic.

Nothing is straight-forward when it comes to Big Pharma. A recent report by Express Scripts Holding, the largest pharmacy-benefit manager (PBM) by prescriptions handled, indicated that while prices for generics have kept overall U.S. spending on production drugs under control, prices for more popular brand-name prescription drugs have surged.

Reporting in the Wall Street Journal, Jon Kamp notes that, “Based on an index tracking the most highly-used branded drugs… prices grew 13.3% between September last year and this year, far outpacing overall economic inflation. At the same time, generic prices plunged about 22%. Overall, spending on prescription drugs rose a ‘relatively muted’ 3.5% over the first nine months of 2012.”

Interestingly, prices rose for some drugs that already face generic competition, such as Pfizer’s cholesterol drug Lipitor and Merck’s asthma treatment Singulair. Steve Miller, Express Scripts’ Chief Medical Officer noted that while competition should bring the market lower, “It is common for manufacturers to cut brand-name prices at first but them lift them later when it is clear who the loyal brand customers are.”

According to the Wall Street Journal, “The Express Scripts report also indicates falling generic prices have helped mask another influence on drug costs: the rise of expensive specialty drugs, which are typically injected treatments for diseases such as cancer and multiple sclerosis. Express Scripts saw a 22.6% spike in spending for such drugs over the first nine months of the year, mainly because of price increases.”

Read the full article here:

“Brand-Name Drug Prices Rise, But Generics Get Cheaper, The Wall Street Journal, November 28, 2012


40 Grove St, Suite 270 Wellesley, MA 02482

  • LinkedIn - White Circle
  • Facebook - White Circle
  • Twitter - White Circle
  • YouTube - White Circle


© Copyright 2020 Scripta Insights, Inc. 

Scripta™ is neither a pharmacy nor a doctor. The benefit service does not tell you what drug to take and does not participate in the drug selection process. Only your physician can determine the medications that are right for you. These alternative medications are options for less costly drugs that physicians may prescribe in place of the medications you are taking now. Scripta has reviewed your current medications only for the purpose of identifying potential cost savings for you to consider with your physician. Scripta has not analyzed the effectiveness or other therapeutic aspects of these medication alternatives. Accordingly, this report and any other forms of communication received from Scripta are not, nor should they be interpreted as, any form of treatment, drug regimen review, or provision of counseling or consultation by a prescriber, pharmacist or pharmacy. Do not stop taking your medication, change your medication, or start taking a new medication without being directed to do so by your physician and filling the prescription under the oversight of a licensed pharmacist. The alternatives set forth above may not be equivalent to your current medication, may interact adversely with your other medications, may not be indicated in light of your other conditions, may cause different or severe side effects, or may be less effective at treating your condition. Medication prices are approximate based on information provided by your pharmacy benefits manager, insurance plans, and/or employer, and may vary from pharmacy to pharmacy. Check with your insurance plan to obtain a full list of pharmacies where your prescriptions can be filled. All information herein is HIPAA protected, treated as highly confidential, and never shared with your employer.

Scripta™, Scripta Insights™ and The Best Meds at the Best Price® are registered trademarks of Scripta Insights, Inc. The contents of the site are for informational purposes only and not intended as a substitute for professional medical advice, diagnosis, or treatment. We do not recommend or endorse any specific prescription drug or pharmacy that may be mentioned herein. Reliance on any information provided by us, our affiliates, employees or others is solely at your own risk.